Vinorelbine as First-Line Treatment in Stage IV Canine Primary Pulmonary Carcinoma.
chemotherapy
dog
lung
staging
vinorelbine
Journal
Veterinary sciences
ISSN: 2306-7381
Titre abrégé: Vet Sci
Pays: Switzerland
ID NLM: 101680127
Informations de publication
Date de publication:
22 Nov 2023
22 Nov 2023
Historique:
received:
23
10
2023
revised:
17
11
2023
accepted:
20
11
2023
medline:
22
12
2023
pubmed:
22
12
2023
entrez:
22
12
2023
Statut:
epublish
Résumé
Vinorelbine (VRL), a semi-synthetic vinca alkaloid commonly used in humans with advanced lung cancer, reaches high concentrations in the lung tissue, has proven antineoplastic activity and a low toxicity profile in dogs. Treatment-naïve, client-owned dogs with a cyto/histological diagnosis of advanced pulmonary carcinoma, selected from a laboratory database and previously subjected to imaging, were enrolled in the study. Vinorelbine (15 mg/m
Identifiants
pubmed: 38133215
pii: vetsci10120664
doi: 10.3390/vetsci10120664
pii:
doi:
Types de publication
Journal Article
Langues
eng